Publication date: June 05, 2024
Photo Credit: Løjtved Foto 2024
– the transfer of the organization from Denmark to Switzerland, Zurich;
– BioLawEurope Joint Publication Proposal: New Edition of “Drafting Agreements in the Biotechnology and Pharmaceutical Industries” by Mark, Anderson Law;
– an in-depth analysis of Member States implications of the Polpharma S.A. v European Medicines Agency case T-611/18 discussed in 2023 in Vienna – presented by Ombeline Degrèze-Péchade, Cabinet Schertenleib;
– current updates on the implementation and clients’ need within ESG regulations regarding life sciences clients and regulatory market, discussed and presented by Igor Pieš & Eliška Toušková, Kastner & Pieš
– analysis of selected aspects of new technologies in regulatory matters within medical devices and medicinal products, including borderline products, digital therapies, data transfers, presented by the lawyers of KIELTYKA GLADKOWSKI